Ushbu ish iqtibos qilgan ishlar

38 ta ish

Ish: ACHIEVEMENTS AND PROSPECTS OF SCIENTIFIC RESEARCH: COVID-19 INFECTION

1. Yaşlı Kadınlarda Üreme Sağlığı

   Kokanalı, Demet, Engin Üstün, Yaprak

   Preprint192 iqtibos

   ABIABI:AkademIndex/2026.other.053922

2. Endothelial cell infection and endotheliitis in COVID-19

   Zsuzsanna Varga, Andreas J. Flammer, Peter Steiger +7

   Boshqa20209 iqtibos

   ABIABI:AkademIndex/2026.other.581199

3. Coronavirus infections and immune responses

   Geng Li, Yaohua Fan, Yanni Lai +9

   Sharh maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.507179

4. Annals of Internal Medicine Drug-Associated Infective Endocarditis Trends : What ' s All the Buzz About ?

   Drug-associated Infective Endocarditis Trends, Buzz About

   Maqola20193 iqtibos

   ABIABI:AkademIndex/2026.other.704064

5. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

   Markus Hoffmann, Hannah Kleine‐Weber, Nadine Krüger +3

   Preprint20202 iqtibos

   ABIABI:AkademIndex/2026.other.507180

6. Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV

   Jared S. Morse, Tyler Lalonde, Shiqing Xu +1

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.507185

7. Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence

   Yuchen Cao, Qixin Deng, Shixue Dai

   Sharh maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.507201

8. Dapsone and doxycycline could be potential treatment modalities for COVID-19

   Ahmed Farouk, Samar Salman

   Boshqa20202 iqtibos

   ABIABI:AkademIndex/2026.other.507210

9. Coronaviruses — drug discovery and therapeutic options

   Alimuddin Zumla, Jasper Fuk‐Woo Chan, Esam I. Azhar +2

   Sharh maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.637129

10. Association between presence of HLA-B*5701, HLA-DR7 , and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

    S. Mallal, David Nolan, Campbell S. Witt +9

    Maqola20022 iqtibos

    ABIABI:AkademIndex/2026.other.674620

11. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704896

12. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704897

13. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704898

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704899

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704900

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704901

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704902

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704903

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704904

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704905

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704906

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704907

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704908

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704909

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.704910